ACC Annual Report - Abramson Cancer Center
ACC Annual Report - Abramson Cancer Center
ACC Annual Report - Abramson Cancer Center
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
12<br />
R ALPH J. & SUZANNE ROBERTS AND BRIAN L. & AILEEN ROBERTS<br />
PARTNER WITH THE MOST COMPREHENSIVE PROTON THERAPY CENTER<br />
PENN Medicine is beginning construction of the Roberts Proton Therapy <strong>Center</strong> – the world’s first fully integrated<br />
proton therapy facility. The Roberts Proton Therapy <strong>Center</strong> is named in honor of Ralph J. and Suzanne Roberts<br />
and Brian L. and Aileen Roberts, who generously pledged $15 million to help create this facility that will treat up<br />
to 3,000 patients a year. Ralph J. Roberts and his son, Brian L. Roberts are both University of Pennsylvania alumni.<br />
“Philadelphia and The University of Pennsylvania have always been special to our family,” said Ralph J. Roberts.<br />
“Suzanne and I are delighted to have the opportunity to give back to these two communities that have meant so<br />
much to us, with a gift that gives life through groundbreaking cancer research and treatment.” Aileen Roberts<br />
remarked that “proton therapy as a treatment for cancer will undoubtedly touch thousands of lives,<br />
both adults and children, and we are fortunate to be a part of that process.”<br />
STEPHEN M. HAHN, M.D.<br />
As a radiation and medical oncologist, as well as an NIH-funded researcher, Stephen<br />
M. Hahn, M.D., brings his many skills and talents to lead one of the nation’s<br />
foremost academic radiation oncology departments. As Chairman,<br />
and previously Vice Chair for Research for the Department<br />
of Radiation Oncology, Hahn has led the expansion of the<br />
department’s research base, which has consistently ranked<br />
first or second in NIH funding. Penn’s <strong>Abramson</strong> <strong>Cancer</strong><br />
<strong>Center</strong> is dedicated to comprehensive care and innovative<br />
treatment options. Adding the Roberts Proton Therapy <strong>Center</strong> to<br />
our repertoire of leading-edge treatments will offer hope and improve<br />
the long-term quality of life for thousands of kids and adults with cancer.<br />
THE RAYMOND<br />
AND RUTH PERELMAN<br />
CENTER FOR<br />
ADVANCED MEDICINE<br />
The Raymond and Ruth Perelman <strong>Center</strong><br />
for Advanced Medicine continues to remain<br />
on schedule for a summer 2008 opening as<br />
the new outpatient facility for the <strong>Abramson</strong> <strong>Cancer</strong><br />
<strong>Center</strong>. The changes in the past few months have been dramatic, and<br />
watching the building come to life has been a wonderful experience<br />
for patients, families and staff alike.<br />
In April, the “topping out” of the building occurred as the final beam<br />
was welded into place. Facing Civic <strong>Center</strong> Boulevard, this beam will<br />
be a visible reminder of the hard work and dedication that have made<br />
the Perelman <strong>Center</strong> possible.<br />
Due to the incredible naming gift of $25 million by Raymond and<br />
Ruth Perelman and the support shown by other donors, our shared<br />
vision to create the most patient-centered, advanced medical facility<br />
possible today is being accomplished. It is incredibly inspiring to see<br />
this emerging building and realize that one day soon this will be the<br />
place people from around the world will come to be cured.<br />
Alliance for <strong>Cancer</strong> Gene Therapy<br />
Barbara and Edward Netter (Penn ‘53) co-founded<br />
Alliance for <strong>Cancer</strong> Gene Therapy (ACGT), the only<br />
public charity dedicated exclusively to cancer gene<br />
therapy research. In six years, ACGT has awarded<br />
30 national grants ($18+ million), including support<br />
for innovative research conducted by Drs. George<br />
Coukos, Carl June and Robert Vonderheide.<br />
Canary Foundation<br />
Don Listwin founded the Canary Foundation in<br />
2004 with a commitment to assisting the next<br />
generation of cancer fighters on the frontlines<br />
of early detection research. The University of<br />
Pennsylvania is proud to be one of eight research<br />
partners, and the Foundation has generously<br />
supported the research efforts of Dr. George Coukos<br />
on the early detection of ovarian cancer.<br />
Evelyn Lauder and<br />
The Breast <strong>Cancer</strong> Research<br />
Foundation (BCRF)<br />
Since 1993, BCRF has raised<br />
over $190 million for breast<br />
cancer research, including<br />
over $5 million in support of<br />
the <strong>Abramson</strong> <strong>Cancer</strong> <strong>Center</strong>.<br />
In 2007, BCRF supported<br />
Drs. Lewis Chodosh, Kate Nathanson, Mark Greene,<br />
Robert Vonderheide, Susan Domchek and Larry<br />
Solin in their research ranging from identifying<br />
breast cancer risks to new therapies.<br />
Independence Blue Cross<br />
Independence Blue Cross (IBC) made a generous<br />
gift to support an endowed chair named in honor<br />
of John H. Glick, M.D. This gift reflects IBC’s deep<br />
appreciation for the care given to G. Fred DiBona,<br />
the former CEO of IBC, who bravely battled renal<br />
cancer. The Glick Chair will bolster Penn’s ability<br />
to continue to recruit top oncologists.<br />
13